美股市场个股详情

AMRN 阿玛琳

添加自选

0.414
+0.004+0.93%

收盘价 03/14 16:00 (美东)

1.71亿总市值-2.07市盈率TTM

关于阿玛琳公司

阿玛琳股份有限公司是一家生物制药公司，专注于商业化和开发治疗药物以改善心血管(CV)健康并降低心血管(CV)风险。其商业化产品包括Vascepa。

公司介绍

公司代码AMRN

公司名称阿玛琳

上市日期1993/04/01

发行价格6.00

成立日期1989

CEOMr. Aaron D. Berg

所属市场纳斯达克

员工数量275

证券类型存托凭证

ADS转换比例1.0 : 1.0

年结日12-31

公司地址One Central Plaza,36 Dame Street,5th Floor

城市Dublin

省份都柏林

国家爱尔兰共和国

邮编2

电话353-1-6699-020

网址http://www.amarincorp.com

董事高管

姓名
职务
年薪

Aaron D. Berg
Director, President and Chief Executive Officer
244.81万

Jonathan N. Provoost
Executive Vice President, Chief Legal and Compliance Officer and Secretary
65.93万

Dr. Steven B. Ketchum, PhD
Executive Vice President, President, Research and Development and Chief Scientific Officer
235.06万

Peter Fishman
Senior Vice President, Chief Financial Officer and Principal Accounting Officer
--

Dr. Odysseas D. Kostas, M.D.
Chairman of the Board
65.04万

Mark DiPaolo, Esq.
Independent Director
62.10万

Keith L. Horn
Independent Director
63.21万

Patrice Bonfiglio
Independent Director
62.69万

Diane E. Sullivan
Independent Director
63.08万

Oliver O'Connor
Independent Director
61.18万

Louis Sterling, III
Independent Director
62.94万

Dr. Paul Cohen, M.D.
Independent Director
62.21万